Anna Rivkin, Ph.D.

Anna Rivkin, Ph.D.

Chief Business OfficeratFoghorn Therapeutics· In the 2024 proxy

Pay in FY2024Foghorn Therapeutics stock -26.8% the same year

Anna Rivkin, Ph.D. was paid $1.5M in FY2024 (Dec). Foghorn Therapeutics stock fell 26.8% that year.

Pay$100 in the stock at the end of FY23 → $73
Pay is from the Summary Compensation Table of each Foghorn Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Foghorn TherapeuticsPublic company · 2 yr
    • Chief Business Officer2024 – Present · 2 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?